TWC
FLGT icon

TD Waterhouse Canada’s Fulgent Genetics FLGT Stock Holding History

TD Waterhouse Canada’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38K Sell
210
-100
-32% -$1.7K ﹤0.01% 2016
2026
Q1 		$5.1K Buy
310
+210
+210% +$4.56K ﹤0.01% 1904
2025
Q4 		$2.62K Buy
+100
New +$2.59K ﹤0.01% 1792
2022
Q3 		– Sell
-46
Closed -$2.55K – 1728
2022
Q2 		$2.55K Buy
+46
New +$2.53K ﹤0.01% 1512
2022
Q1 		– Sell
-160
Closed -$13.8K – 1809
2021
Q4 		$13.8K Buy
+160
New +$14.1K ﹤0.01% 1280

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

TD Waterhouse Canada's FLGT Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Fulgent Genetics (FLGT) stake by 32% in Q2 2026, selling an estimated $1.7K and leaving 210 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

TD Waterhouse Canada first reported a position in FLGT in Q4 2021 and has held it in 5 quarters since. The position peaked at $13.8K in Q4 2021. 49 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • TD Waterhouse Canada held 210 shares of Fulgent Genetics worth $4.38K as of Q2 2026.
  • TD Waterhouse Canada sold 100 Fulgent Genetics shares in Q2 2026, an estimated $1.7K.
  • Fulgent Genetics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2016 holding.
  • TD Waterhouse Canada first reported a position in Fulgent Genetics in Q4 2021 and has held it in 5 quarters since.
  • TD Waterhouse Canada's Fulgent Genetics position peaked at $13.8K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.